Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 301 participants.
Also called NCT05513937
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 301 participants
- Registry
-
NCT05513937
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Bulgaria
- Registry status
- Completed
Technical summary
Registry record NCT05513937. Non-randomized; no masking; primary purpose treatment. Start 2022-05-12 (actual); primary completion 2022-11-15 (actual). Results posted on 2025-02-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
- Acronym
- Botticelli
- Condition
- Hypertension
- Intervention (Drug)
- Nebivolol
- Intervention (Drug)
- Amlodipine
- Lead sponsor
- Menarini International Operations Luxembourg SA
Record details
- Record id
cardio:ct-nct05513937- Content hash
f0754d0cb5dec2e908bd19a5c8bdad82ea6abf555de33c40faf60fc0026cd66d